On Thursday, June 23, 2016, the Pharmacy Compounding Advisory Committee (PCAC) voted on six bulk drug substances that were nominated for inclusion on the section 503A bulk drug substances list, also known as the “Bulk Substances Allowed List.”
In addition, the Committee was presented with information about obtaining access to investigational new drugs under expanded access programs.
See the SAC Tracker report